Enveric Biosciences Inc. logo

Enveric Biosciences Inc.

ENVB | NASDAQ
Chart Builder DCF Calculator
$1.54
-$0.02 (-1.28%)
At close: Sep 22, 2026, 4:00 PM ET
$1.59
+$0.05 (+3.25%)
After-hours: Sep 22, 2026, 7:30 PM ET

Market Data

Market Cap
$931.34K
Enterprise Value
$-7.36M
Beta
1.11
Average Volume
203.54K
Shares Outstanding (Diluted)
3.99M
Shares Change YoY
1743.22%
Institutional Ownership
3.64%
Exchange
NASDAQ
ISIN
US29405E5050

Price Performance

Price Change 1M
8.3%
Price Change 3M
15.6%
Price Change 6M
-20.8%
Price Change YTD
-57.5%
Price Change 1Y
-77.7%
Price Change 3Y
-99.6%
Price Change 5Y
-100.0%
1M CAGR (ann.)
0.7%
1Y CAGR (ann.)
-79.4%
5Y CAGR (ann.)
-85.6%
All-Time CAGR
-50.2%

Valuation

PE Ratio
-0.09
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
N/A
Forward PS
0.10
PB Ratio
0.12
P/FCF Ratio
-0.11
P/Adj. FCF Ratio
-0.10
P/OCF Ratio
-0.73
EV/Sales
N/A
EV/EBIT
1.29
EV/EBITDA
0.86
EV/FCF
0.86
Earnings Yield
-1055.1%
FCF Yield
-919.2%
Adj. FCF Yield
-988.1%

Financial Health

Net Cash
$8.3M
Total Debt
$0
Cash & Short-Term Investments
$8.3M
Total Assets
$8.94M
Current Ratio
10.21
Quick Ratio
10.21
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
-10,329.56
Altman Z-Score
-19.10
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-7.5%

Returns

Return on Assets
-97.6%
Return on Equity
-168.1%
Return on Invested Capital
-108.0%
Return on Capital Employed
-108.0%
Return on Tangible Assets
-97.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
N/A
Revenue CAGR 10Y
-41.3%
EPS CAGR 3Y
0.8%
EPS CAGR 5Y
-37.0%
EPS CAGR 10Y
30.3%
FCF CAGR 3Y
8.5%
FCF CAGR 5Y
22.4%
FCF CAGR 10Y
-6.4%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-8.56M
Free Cash Flow
$-8.56M
Adj. Free Cash Flow
$-9.2M
FCF Per Share
-$2.15
OCF Per Share
-$2.15
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-117.09K
Operating Income
$-8.73M
EBITDA
$-8.57M
Net Income
$-8.73M
EPS (Diluted)
-$16.46
Revenue / Employee
N/A
Profit / Employee
$-1.45M
Employees
6

© 2026 bestshares.com. All rights reserved.